Academic Drug Discovery – how to secure that preclinical findings reach the patients

University of Copenhagen, Lund University, and Medicon Valley Alliance invite you to Academic Drug Discovery – how to secure preclinical findings reach the patients:

The Medicon Valley universities have many research activities within early drug discovery and they offer a wide range of know-how and research within new therapeutic goals and new and innovative methods to develop drugs. These activities can support drug development not only at the universities but also at other life-science institutions/companies in the region. However, there is currently no clear formalized initiative between academic preclinical drug discovery, clinical trials and the region’s life science industry. How can we ensure maximum exchange between preclinical research findings, related knowledge and technologies from the academia and the life-science industry and thereby facilitate the progression of novel drug candidates so that they reach all the way to patients and create social benefits?